QQ客服 官方微博 反馈留言

	99Tc-MDP treatment for the therapy of rheumatoid arthritis, choroidal neovascularisation and graves’ ophthalmopathy (Review)
	Wu Q.; Ni Y.; Yang Q.; Sun H.
刊名	Biomedical Reports
	2016
卷号	4期号:4页码:400-402
关键词	Choroidal neovascularization Graves’ ophthalmopath Rheumatoid arthritis Technetium 99 conjugated with methylene diphosphonate Therapy
DOI	10.3892/br.2016.609
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4711687
专题	山东大学
作者单位	1.Departments of Rheumatology and Immunology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, China 2.[ N
推荐引用方式 GB/T 7714	Wu Q.,Ni Y.,Yang Q.,et al. 99Tc-MDP treatment for the therapy of rheumatoid arthritis, choroidal neovascularisation and graves’ ophthalmopathy (Review)[J]. Biomedical Reports,2016,4(4):400-402.
APA	Wu Q.,Ni Y.,Yang Q.,&Sun H..(2016).99Tc-MDP treatment for the therapy of rheumatoid arthritis, choroidal neovascularisation and graves’ ophthalmopathy (Review).Biomedical Reports,4(4),400-402.
MLA	Wu Q.,et al."99Tc-MDP treatment for the therapy of rheumatoid arthritis, choroidal neovascularisation and graves’ ophthalmopathy (Review)".Biomedical Reports 4.4(2016):400-402.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。